NCT07185880
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07185880
Title A Phase 1 Study of the Safety and Tolerability of MT-125 in GBM Patients (STAR-GBM)
Acronym STAR-GBM
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Myosin Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Phoenix Arizona 85054 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field